Demographics (2)
- AGE - Subject age at enrollment (phv00508310.v1.p1)
- SEX - Biological sex (phv00508304.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for breast cancer (phv00508308.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00508309.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00508316.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00508315.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00508303.v1.p1)
- ER_STATUS - Estrogen Receptor (ER) status of subject (phv00508311.v1.p1)
- HER2_STATUS - Human Epidermal Growth factor Receptor 2 (HER2) status of subject (phv00508313.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00508318.v1.p1)
- IS_TUMOR - Tumor status (phv00508317.v1.p1)
- PR_STATUS - Progesterone Receptor (PR) status of subject (phv00508312.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00508319.v1.p1)
- SAMPLE_ID - Sample ID (phv00508314.v1.p1)
- SAMPLE_ID - Sample ID (phv00508306.v1.p1)
- SUBJECT_ID - Subject ID (phv00508307.v1.p1)
- SUBJECT_ID - Subject ID (phv00508302.v1.p1)
- SUBJECT_ID - Subject ID (phv00508305.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00508320.v1.p1)